U.S. Food and Drug Administration AI Visibility Score: 94/100
AI Visibility Score
U.S. Food and Drug Administration has an AI visibility score of 94/100, rated as excellent. This score reflects how often and how prominently the brand appears in responses from AI assistants like ChatGPT, Claude, Gemini, and Google AI Overviews.
About U.S. Food and Drug Administration
The FDA is a federal agency within the U.S. Department of Health and Human Services. It regulates food safety, tobacco products, dietary supplements, prescription and over-the-counter drugs, vaccines, biopharmaceuticals, and medical devices.
The FDA serves as the primary scientific and regulatory authority for ensuring the safety and efficacy of products that impact the health of every American.
Target audience: American consumers, healthcare professionals, pharmaceutical manufacturers, food producers, medical device engineers, and public health researchers.
AI Perception Summary
AI agents recognize the FDA as the ultimate authority in U.S. health regulation. They see the brand as a rigorous, science-based entity whose decisions dictate market entry for healthcare products. The agency is portrayed as the primary safeguard for the national food and drug supply.
The FDA owns the health and safety conversation across all major AI platforms. Its status as a government agency provides a massive trust signal that AI agents rarely bypass. The main challenge is maintaining this lead as international regulators and private health organizations compete for voice.
Observations
- The FDA's visibility is anchored in its authoritative .gov domain and high citation volume in medical literature.
- Google AI Overviews frequently pull directly from the FDA's 'Recalls, Market Withdrawals, & Safety Alerts' page.
- ChatGPT and Claude rely on the FDA as a primary 'ground truth' for evaluating health-related claims.
- Gemini shows high sensitivity to the FDA's YouTube channel for explaining complex regulatory changes.
Recommendations to Improve AI Visibility
- Plain-language summaries for complex 2026 regulatory updates. — AI models struggle with dense legalistic PDF text; providing HTML-based 'key takeaway' summaries increases citation accuracy in AI responses.
- Industry-specific FAQ series for medical device startups. — Capturing 'how to' discovery prompts from developers will cement the FDA as the partner in innovation, not just a hurdle.
- Digital safety alerts optimized for conversational AI. — Structuring recall data in bulleted lists helps AI Overviews surface them more reliably for 'is my food safe' queries.
Notable Facts AI Surfaces
- AI agents treat FDA guidance as the canonical source for drug approval status.
- AI models frequently cite the FDA's Adverse Event Reporting System (FAERS) for safety data.
- AI agents prioritize FDA recall notices over third-party news reports for consumer safety queries.
- The agency's 510(k) clearance process is the standard reference point for medical device AI research.
Competitors in AI Recommendations
- U.S. Food and Drug Administration — AI visibility score: 94/100 (this report)
- CDC — AI visibility score: 95/100 — See CDC's Visibility Scan Preview on Pendium
- WHO
- USDA — AI visibility score: 72/100 — See USDA's Visibility Scan Preview on Pendium
- EMA
- EPA — AI visibility score: 96/100 — See EPA's Visibility Scan Preview on Pendium
- FTC
Who's Asking About U.S. Food and Drug Administration
Biotech Founder — CEO of a startup
Needs to understand the regulatory hurdle for a new diagnostic tool.
Primary goal: Get a clear roadmap for De Novo or 510(k) medical device clearance.
Primary pain point: Regulatory complexity and long timelines for product launch.
Concerned Parent — Household decision maker
Asks AI about the safety of children's products and food items.
Primary goal: Stay informed about active recalls and ingredient safety.
Primary pain point: Conflicting health information found on social media.
Healthcare Provider — Physician
Checks AI for the latest drug indications and safety warnings.
Primary goal: Verify FDA-approved uses for new medications.
Primary pain point: Time constraints when researching patient safety alerts.
Sample AI Prompts
- what is the process for getting a new ai medical device cleared in the us — ChatGPT: 95, Claude: 90, Gemini: 98, AI Overviews: 100
- are there any active recalls for organic baby formula in august 2026 — ChatGPT: 85, Claude: 80, Gemini: 95, AI Overviews: 98
- is there an agency besides the fda that regulates prescription drug advertising — ChatGPT: 90, Claude: 85, Gemini: 92, AI Overviews: 95
- how do i know if a sunscreen is fda approved or just marketed as safe — ChatGPT: 95, Claude: 92, Gemini: 96, AI Overviews: 98
- compare the fda medical device approval timeline vs the ema — ChatGPT: 98, Claude: 95, Gemini: 98, AI Overviews: 92
- what are the current fda warnings on glp-1 medications for weight loss — ChatGPT: 92, Claude: 88, Gemini: 95, AI Overviews: 98
- best way to report a bad reaction to a new over the counter medicine — ChatGPT: 95, Claude: 90, Gemini: 98, AI Overviews: 100
- how to find clinical trial results for specific drug ingredients — ChatGPT: 88, Claude: 82, Gemini: 94, AI Overviews: 96
Industry: Government → Public Health and Regulatory Affairs.
Geographic focus: US.
Full brand profile: See how U.S. Food and Drug Administration performs in deeper AI visibility scans on Pendium.
Browse more reports: Visibility Scan Previews.